Zoetis named one of America's best employers, says ForbesApril 18, 2019For the fourth year in a row, Zoetis has been named one of America's best midsize employers, according to Forbes Magazine. The list comprises 150 companies. It is based on an independent survey among a sample of 50,000 American employees working for companies with at least 1,000 people in their U.S. operations. The most important factor in the assessment was the willingness to recommend one's own employer. Employees were consulted anonymously through online access panels allowing them to express their opinions. "At Zoetis, we know our people shape our reputation as a great place to work and drive our success," says Roxanne Lagano, Zoetis executive vice president, chief human resources officer and communications. "We are proud of the culture we have at our company, and we are excited our colleagues and others recommend Zoetis as one of America's best employers."
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
What veterinarians can learn from the Sears bankruptcyFebruary 20, 2019Sears, one of America's longest standing household names, recently raised the white flag and filed for bankruptcy. Started by Robert Sears in 1886, the company bearing his name clearly struggled in the past few years. The reasons are important and somewhat universal lessons to be applied. So how can veterinarians avoid mistakes that brought a 133-year-old iconic business to its knees? Adapt or die Sears was a pioneer in catalog sales, but slow to change with the times. More recently, it struggled to compete with Walmart and other big box stores. Similarly, veterinary practices face competition from multiple "players," including low-cost vaccine businesses (e.g. farm stores, feed stores, human pharmacies, pet stores), spay and neuter clinics, and even local family practices. This has profoundly affected the profitability of practices that relied heavily on "yearly shots," instead of focusing on the importance of (bi)yearly physical exams. Sadly, this philosophy made vaccines look like commodities, which means clients are likely to gravitate to the cheaper provider. Another factor that has historically affected revenue is the development of three-year vaccines. Again, those of us who didn't stress the value and importance of a (bi)annual exam are now facing clients who feel they …
Henry Schein named one of world's most admired companies by FortuneJanuary 25, 2019Henry Schein has been named to Fortune’s list of World’s Most Admired Companies for the 18th consecutive year.
